K. J. Cortez, E. Roilides, F. Quiroz-telles, J. Meletiadis, C. Antachopoulos et al., Infections caused by Scedosporium spp, Clin Microbiol Rev, vol.21, issue.1, pp.157-97, 2008.

S. J. Taj-aldeen, B. Rammaert, M. Gamaletsou, N. V. Sipsas, V. Zeller et al., Osteoarticular infections caused by non-Aspergillus filamentous fungi in adult and pediatric patients: a systematic review, Medicine (Baltimore), vol.94, issue.50, p.2078, 2015.

C. L. Halliday, S. Chen, S. E. Kidd, S. Van-hal, B. Chapman et al., Antifungal susceptibilities of non-Aspergillus filamentous fungi causing invasive infection in Australia: support for current antifungal guideline recommendations, Int J Antimicrob Agents, vol.48, issue.4, pp.453-461, 2016.

A. M. Tortorano, M. Richardson, E. Roilides, A. Van-diepeningen, M. Caira et al., ESCMID and ECMM joint guidelines on diagnosis and management of hyalohyphomycosis: Fusarium spp., Scedosporium spp. and others, Clin Microbiol Infect, vol.20, pp.27-46, 2014.

J. Meletiadis, J. W. Mouton, J. Meis, and P. E. Verweij, In vitro drug interaction modeling of combinations of azoles with terbinafine against clinical Scedosporium prolificans isolates, Antimicrob Agents Chemother, vol.47, issue.1, pp.106-123, 2003.

A. Jover-saénz, V. Altermir-martínez, F. Barcenilla-gaite, and S. Garrido-calvo, Infectious arthritis with osteomyelitis due to Scedosporium prolificans in an immunocompetent patient, Med Clínica, vol.146, issue.3, pp.15-21, 2016.

J. A. Trubiano, E. Paratz, M. Wolf, B. W. Teh, M. Todaro et al., Disseminated Scedosporium prolificans infection in an « extensive metaboliser »: navigating the minefield of drug interactions and pharmacogenomics, Mycoses, vol.57, issue.9, pp.572-578, 2014.

F. Compain, F. Botterel, E. Sitterlé, A. Paugam, M. Bougnoux et al., In vitro activity of miltefosine in combination with voriconazole or amphotericin B against clinical isolates of Scedosporium spp, J Med Microbiol, vol.64, pp.309-320, 2015.

A. M. Kesson, M. C. Bellemore, T. J. O'mara, D. H. Ellis, and T. C. Sorrell, Scedosporium prolificans osteomyelitis in an immunocompetent child treated with a novel agent, hexadecylphospocholine (miltefosine), in combination with terbinafine and voriconazole: a case report, Clin Infect Dis, vol.48, issue.9, pp.1257-61, 2009.

M. T. Levine and P. H. Chandrasekar, Adverse effects of voriconazole: over a decade of use, Clin Transplant, vol.30, issue.11, pp.1377-86, 2016.